News | 16 August 2012
An unprecedented number of drugs have recently begun to face generic competition. That includes the cholesterol fighter Lipitor and blood thinner Plavix. Once multiple generic versions hit the market, they are often priced as much as 90 percent below ...
Click on the link to read the full article at Boston Globe
(This link will open in a new window)